Regeneron Pharmaceuticals, Inc.

Allworth Financial LP REGN

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/5/2026

Shares

2,183

Value ($000)

1,685

Weight

0.0%

2020 Q2 - 2025 Q4 (21 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/5/2026	1,685	0.0%	2,183	12/31/2025
2025 Q2	8/7/2025	522	0.0%	994	6/30/2025
2025 Q1	4/30/2025	493	0.0%	821	3/31/2025
2024 Q4	1/30/2025	651	0.0%	958	12/31/2024
2024 Q3	10/23/2024	745	0.0%	709	9/30/2024
2024 Q2	7/24/2024	703	0.0%	661	6/30/2024
2024 Q1	4/25/2024	508	0.0%	528	3/31/2024
2023 Q4	1/24/2024	318	0.0%	362	12/31/2023
2023 Q3	10/31/2023	295	0.0%	358	9/30/2023
2023 Q2	7/18/2023	246	0.0%	342	6/30/2023
2023 Q1	4/18/2023	134	0.0%	163	3/31/2023
2022 Q4	1/13/2023	100	0.0%	139	12/31/2022
2022 Q3	11/14/2022	89	0.0%	129	9/30/2022
2022 Q2	7/13/2022	54	0.0%	92	6/30/2022
2022 Q1	4/22/2022	33	0.0%	47	3/31/2022
2021 Q4	1/21/2022	35	0.0%	55	12/31/2021
2021 Q3	11/2/2021	19	0.0%	32	9/30/2021
2021 Q1	4/29/2021	17	0.0%	36	3/31/2021
2020 Q4	1/26/2021	17	0.0%	36	12/31/2020
2020 Q3	11/3/2020	20	0.0%	36	9/30/2020
2020 Q2	7/24/2020	22	0.0%	36	6/30/2020